In people 75 and older, a common diabetes drug didn’t look riskier than the alternative
In a cohort study published Oct. 27, 2026, in Diabetes Care, people 75 and older with type 2 diabetes who started an SGLT2 inhibitor had lower risks of acute kidney injury and…